Close
Digital Health & Ai Innovation summit 2026
APE 2026

Astro brochure helps patients to understand types of radiation therapy

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Natera Adds ctDNA-Based MRD Tests with...

In an all-stock transaction, Natera, which is the cell-free...

FDA Launches Technology-Enabled Meaningful Patient Outcomes

Technology-Enabled Meaningful Patient Outcomes – TEMPO has been launched...

US Healthcare Providers to Benefit from...

The federal government has formally withdrawn the Biden-era minimum...

The American Society for Radiation Oncology (ASTRO) has recently updated its popular patient brochure, Radiation Therapy for Breast Cancer.

Radiation Therapy for Breast Cancer is a four-color brochure that helps women understand the types of radiation therapy they may be offered, including newer treatments like three-dimensional radiation therapy (3DCRT), intensity modulated radiation therapy (IMRT) and breast brachytherapy. The brochure also explains possible side effects, how to get more information on clinical trials and support groups, and offers tips for caring for yourself during treatment. said Gregory Patton, M.D., chair of ASTRO's Communications Committee and a radiation oncologist at Northwest Cancer Specialists, P.C., in Portland, Ore said, The diagnosis of breast cancer can be overwhelming. Recognizing this, ASTRO created its brochures to educate patients on the lifesaving benefits of radiation therapy. We continue to update our brochures on a regular basis, so that patients can have the most upto- date information when making treatment decisions.

Latest stories

Related stories

Natera Adds ctDNA-Based MRD Tests with Acquisition of Foresight Diagnostics

In an all-stock transaction, Natera, which is the cell-free...

FDA Launches Technology-Enabled Meaningful Patient Outcomes

Technology-Enabled Meaningful Patient Outcomes – TEMPO has been launched...

US Healthcare Providers to Benefit from Minimum Nurse Staffing Rule Repeal

The federal government has formally withdrawn the Biden-era minimum...

Purehealth, Dorchester Partner to Bring Luxury Hospitality in Healthcare

PureHealth has gone on to announce a first-of-its-kind partnership...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »